Tuesday, June 30, 2026 Live from SEC EDGAR

The Wire Search Saved

···

FilingIndex

AI-powered intelligence over every SEC filing. Search in plain English. Free.

Browse

Sectors
Themes
Search

Data

SEC EDGAR
About

Legal

Privacy
Disclaimer

© 2026 FilingIndex · Data sourced from SEC EDGAR (public domain).Not investment advice.

AGMB — Agomab Therapeutics NV SEC Filings | FilingIndex

AGMBNasdaq

Agomab Therapeutics NV

Biological Products, (No Diagnostic Substances) · C9 · CIK 2020932

Developing novel disease-modifying therapies for fibro-inflammatory diseases

+ Watch View on EDGAR ↗

$473M

Market cap

$17.82

Last close

+29.0%

1D

+50.5%

5D

200K

Volume

Price · last 39 sessions+47.2%

May 4L $9.61 · H $17.82Jun 29

7

Total filings

Jun 23, 2026

Last filing

12/31

Fiscal year end

All 6-K · 5 20-F · 1 424B4 · 1 SC 13D · 1

SC 13DSC 13DFeb 17, 2026

Similar companies

Comparable business profile · signals at a glance

PRQRProQR Therapeutics N.V.$151.7M+19.6%SRRKScholar Rock Holding Corp$5.3B+0.4%APGEApogee Therapeutics, Inc.🔥$6.7B+0.1%ADCTADC Therapeutics SA$133.6M+1.0%MDGLMADRIGAL PHARMACEUTICALS, INC.

$11.1B

+2.9%

CGENCOMPUGEN LTD$193.0M+3.4%